News

Patients with systemic lupus erythematosus (SLE) show significantly higher rates for dementia compared to healthy people, according to a large cross-sectional Israeli study. The research, “High proportions of dementia among SLE patients: A big data analysis,” was published in the journal International Journal of Geriatric Psychiatry. Lupus…

Progentec Diagnostics is closer to marketing a new set of tools for predicting lupus flares after obtaining $1.25 million in financing. The Oklahoma Medical Research Foundation created the technology the company is using. Progentec is collaborating with Dr. Judith James, a lupus researcher who developed the technology, to refine the platform.

Patients with lupus found the Patient Reported Outcomes Measurement Information System (PROMIS) assessment tool to be relevant, valuable, and useful in improving clinical care, according to a new study. Results from the study, which was conducted at the Hospital for Special Surgery (HSS) in New York, was presented at the…

Cellenkos announced a new collaboration with The University of Texas MD Anderson Cancer Center to develop cord blood regulatory T-cell (CB TREG) therapeutics for autoimmune diseases and inflammatory disorders such as lupus. The company will fund up to $10 million for the CB TREG program over five years. Led by Simrit Parmar…

The rate of cardiovascular events in lupus patients increased during the second half of a 15-year period, a long-term study found. Cardiovascular events included angina (chest pain), fatal or nonfatal acute myocardial infarction (MI), transient ischemic attack (“mini-stroke”), fatal and nonfatal stroke, and cardiovascular (CV) death. The study, titled “…

With a $387,000 grant from the National Institutes of Health, researchers at the University of Houston are developing a new diagnostic test for lupus patients that uses saliva instead of the standard invasive methods. Led by Chandra Mohan, MD, PhD, and a Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering,…